OPCML intronic transcript 1 (non-protein coding) (OPCML-IT1)

OPCML intronic transcript 1 (OPCML-IT1) is a long non-coding RNA transcribed from the intronic region of the OPCML gene. Unlike the protein-coding OPCML, which has recognized tumor suppressor functions in multiple cancers, OPCML-IT1 lacks known protein-coding capacity and is primarily annotated as a non-protein-coding RNA. Long non-coding RNAs such as OPCML-IT1 can regulate gene expression epigenetically, transcriptionally, or post-transcriptionally, but the specific biological functions, disease associations, and pharmacology of OPCML-IT1 remain uncharacterized[3][6][1]. Most available information relates to the protein-coding OPCML gene, not OPCML-IT1. If targeting, drug development, or disease roles are sought, OPCML (the protein) is the relevant entity, not OPCML-IT1. There are no known drugs nor established biomarker or disease applications for OPCML-IT1. If you require structured metadata for use in bioinformatics or drug discovery databases, OPCML-IT1 should be flagged as a non-target, long non-coding RNA with insufficient annotation for target-based research[3][6][1].

Other names

OPCML-IT1OPCML intronic transcript 1OPCML intronic transcript 1 (non-protein coding)

None reported (As it is not a typical drug target, there are no mechanisms of drug action associated with OPCML-IT1.)